FECGX Mutual Fund Forecast & Price Targets

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

FECGX Analyst Rating

Moderate Buy

827 Buy

277 Hold

17 Sell

Based on the consensus analyst ratings on 1,121 stocks held in FECGX.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

FECGX Analyst Price Target

Average Price Target

$32.83

Based on 1,121 Wall Street analysts offering 12 month price targets to Fidelity Small Cap Growth Index Fund holdings in the last 3 months. The average price target is $32.83 with a high forecast of $40.36 and a low forecast of $26.49. The average price target represents a 32.21% change from the last price of $24.83.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"23":"$23","32":"$32","41":"$41","27.5":"$27.5","36.5":"$36.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":40.359,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$40.36</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":32.827,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$32.83</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":26.486,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$26.49</span>\n  </div></div>","useHTML":true}}],"tickPositions":[23,27.5,32,36.5,41],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.18,27.270692307692308,28.361384615384615,29.452076923076923,30.54276923076923,31.63346153846154,32.72415384615385,33.814846153846155,34.90553846153846,35.99623076923077,37.08692307692308,38.177615384615386,39.268307692307694,{"y":40.359,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.18,26.691307692307692,27.202615384615385,27.713923076923077,28.22523076923077,28.736538461538462,29.247846153846154,29.759153846153843,30.27046153846154,30.78176923076923,31.293076923076924,31.804384615384613,32.31569230769231,{"y":32.827,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.18,26.20353846153846,26.227076923076922,26.250615384615383,26.274153846153848,26.29769230769231,26.32123076923077,26.34476923076923,26.368307692307692,26.391846153846153,26.415384615384617,26.43892307692308,26.46246153846154,{"y":26.486,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":25.39,"date":1717372800000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.27,"date":1719792000000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.7,"date":1722470400000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.08,"date":1725321600000,"info":"<div>Price: <b>$26<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.02,"date":1727740800000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.34,"date":1730419200000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":30.31,"date":1733097600000,"info":"<div>Price: <b>$30<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.8,"date":1735776000000,"info":"<div>Price: <b>$28<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":28.28,"date":1738540800000,"info":"<div>Price: <b>$28<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.75,"date":1740960000000,"info":"<div>Price: <b>$26<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":24.64,"date":1743465600000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":24.64,"date":1746057600000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.18,"date":1748822400000,"info":"<div>Price: <b>$26<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$40.36

Average Price Target$32.83

Lowest Price Target$26.49

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

FECGX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

TNYA

Tenaya Therapeutics, Inc.

―

8 Buy

0 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

FBLG

FibroBiologics, Inc.

―

2 Buy

0 Hold

0 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CAMP

CAMP4 Therapeutics Corporation

―

5 Buy

0 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ARTV

Artiva Biotherapeutics, Inc.

―

5 Buy

0 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ZURA

Zura Bio Limited

―

4 Buy

1 Hold

0 Sell

Strong Buy

―

FECGX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

MODV

Modivcare Inc.

―

0 Buy

2 Hold

0 Sell

Hold

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

NVTS

Navitas Semiconductor Corporation

―

3 Buy

1 Hold

1 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

SST

System1 Inc.

―

1 Buy

0 Hold

0 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CRCT

Cricut, Inc.

―

0 Buy

1 Hold

3 Sell

Moderate Sell

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

BYND

Beyond Meat

―

0 Buy

2 Hold

3 Sell

Moderate Sell

―

FECGX Mutual Fund FAQ

What is FECGX’s average 12-month price target, according to analysts?

Based on analyst ratings, Fidelity Small Cap Growth Index Fund’s 12-month average price target is 32.83.

What is FECGX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for FECGX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is FECGX a Buy, Sell or Hold?

Fidelity Small Cap Growth Index Fund has a consensus rating of Moderate Buy which is based on 827 buy ratings, 277 hold ratings and 17 sell ratings.

What is Fidelity Small Cap Growth Index Fund’s price target?

The average price target for Fidelity Small Cap Growth Index Fund is 32.83. This is based on 1121 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $40.36 ,the lowest forecast is $26.49. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about Fidelity Small Cap Growth Index Fund?

Fidelity Small Cap Growth Index Fund’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1121 Wall Streets Analysts.

How can I buy shares of FECGX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing